Cargando…
A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topica...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371730/ https://www.ncbi.nlm.nih.gov/pubmed/30886475 http://dx.doi.org/10.4103/JCAS.JCAS_130_17 |
_version_ | 1783394621369352192 |
---|---|
author | Kumar, Muriki K. Inamadar, Arun C. Palit, Aparna |
author_facet | Kumar, Muriki K. Inamadar, Arun C. Palit, Aparna |
author_sort | Kumar, Muriki K. |
collection | PubMed |
description | BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topical minoxidil is the first-line treatment for AGA. Many adjuvant treatment modalities have been used synergistically with minoxidil. Microneedling is one among such adjuvant treatments, which works by various mechanisms to stimulate the dermal papillary cells that play a key role in hair growth. AIM: To compare the efficacy of microneedling along with topical minoxidil and topical minoxidil alone in the treatment of AGA in men. MATERIALS AND METHODS: Sixty-eight men with Norwood–Hamilton grade III and IV AGA were recruited for the study. After randomization, one group was treated with weekly microneedling and twice daily application of 5% minoxidil solution and the other group was treated with twice daily application of 5% minoxidil solution alone. Global photographs were taken at baseline (pretreatment) and at end of the study duration. Trichoscopic images were taken from a targeted fixed area before treatment (baseline) and at end of the therapy from where hair count was also carried out. The two primary efficacy parameters were assessed: increase in the hair count from that of the baseline and patient self-assessment of hair growth at the end of the study. RESULTS: The mean increase in hair count in the targeted area of one square inch at the end of the treatment was significantly greater for the combination treatment group (12.52/inch(2)) compared to that for the minoxidil alone group (1.89/inch(2)). Four patients in the “microneedling plus topical minoxidil” group reported a 50% improvement versus none in the “minoxidil alone” group. CONCLUSION: Our study showed that the combination of microneedling and topical minoxidil treatment was superior compared to topical minoxidil alone with regard to increase in the hair count and patient satisfaction, although the response achieved was not cosmetically significant. |
format | Online Article Text |
id | pubmed-6371730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-63717302019-03-18 A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia Kumar, Muriki K. Inamadar, Arun C. Palit, Aparna J Cutan Aesthet Surg Original Article BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topical minoxidil is the first-line treatment for AGA. Many adjuvant treatment modalities have been used synergistically with minoxidil. Microneedling is one among such adjuvant treatments, which works by various mechanisms to stimulate the dermal papillary cells that play a key role in hair growth. AIM: To compare the efficacy of microneedling along with topical minoxidil and topical minoxidil alone in the treatment of AGA in men. MATERIALS AND METHODS: Sixty-eight men with Norwood–Hamilton grade III and IV AGA were recruited for the study. After randomization, one group was treated with weekly microneedling and twice daily application of 5% minoxidil solution and the other group was treated with twice daily application of 5% minoxidil solution alone. Global photographs were taken at baseline (pretreatment) and at end of the study duration. Trichoscopic images were taken from a targeted fixed area before treatment (baseline) and at end of the therapy from where hair count was also carried out. The two primary efficacy parameters were assessed: increase in the hair count from that of the baseline and patient self-assessment of hair growth at the end of the study. RESULTS: The mean increase in hair count in the targeted area of one square inch at the end of the treatment was significantly greater for the combination treatment group (12.52/inch(2)) compared to that for the minoxidil alone group (1.89/inch(2)). Four patients in the “microneedling plus topical minoxidil” group reported a 50% improvement versus none in the “minoxidil alone” group. CONCLUSION: Our study showed that the combination of microneedling and topical minoxidil treatment was superior compared to topical minoxidil alone with regard to increase in the hair count and patient satisfaction, although the response achieved was not cosmetically significant. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6371730/ /pubmed/30886475 http://dx.doi.org/10.4103/JCAS.JCAS_130_17 Text en Copyright: © 2019 Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumar, Muriki K. Inamadar, Arun C. Palit, Aparna A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title | A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title_full | A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title_fullStr | A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title_full_unstemmed | A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title_short | A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia |
title_sort | randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371730/ https://www.ncbi.nlm.nih.gov/pubmed/30886475 http://dx.doi.org/10.4103/JCAS.JCAS_130_17 |
work_keys_str_mv | AT kumarmurikik arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia AT inamadararunc arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia AT palitaparna arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia AT kumarmurikik randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia AT inamadararunc randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia AT palitaparna randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia |